Lexaria Bioscience Corp. LXRP Archives - Page 13 of 27

FridayDec 28, 2018 9:54 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) to Attend Cantech Investment Conference 2019, January 29-30 in Toronto

Summit will highlight 100+ leading technology firms in the international cannabinoid-derived pharmaceuticals space; more than 3,500 investors are expected to attend LXRP is a drug delivery platform innovator with a growing IP portfolio of 10 patents granted and more than 50 patents filed globally LXRP out-licenses its delivery technology, such as its proprietary DehydraTECH; it holds a patent for oral delivery of all cannabinoids Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX), a drug delivery platform innovator, will exhibit at the Cantech Investment Conference 2019, taking place on January 29-30 in Toronto, and it will participate in a specialized event where…

ThursdayDec 27, 2018 12:47 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Increases the Performance of Products for Third-Party Partners

Changing the way cannabinoids and nicotine enter the blood stream Enhancing products worldwide, with patents issued and pending in more than 40 countries Providing a powerful new delivery method with a cost of less than a penny per serving to implement Smoking is an efficient way to absorb cannabis and nicotine into the blood stream. However, it is also a health hazard that takes the lives of over six million people each year through smoking-related diseases. What would it mean for the cannabis, nicotine and other medicinal industries if the dangers of lighting up were eliminated from the equation? What…

WednesdayDec 26, 2018 3:02 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) New Laboratory Construction Advances Rapidly

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a biotechnology company and drug delivery platform innovator, has submitted a Health Canada research application for a license to allow in-house research to be conducted at its Kelowna-based laboratory. A recent article further discussing the company reads, “Lexaria submitted its research application under Health Canada’s Cannabis Tracking and Licensing System for the operation of a research and development (R&D) laboratory to work with cannabinoids within the company’s new Kelowna head office, now under construction. In fact, Lexaria will commence experimental work on nicotine formulations, NSAIDs, vitamins and other bioactive compounds of interest after the…

ThursdayDec 20, 2018 2:22 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Aims to Cut Costs with In-House R&D Laboratory

Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) recently submitted a Health Canada research application for a license that will permit in-house research in its new Kelowna-based research and development (“R&D”) laboratory. Construction of the new lab, which will be located within Lexaria’s new head office, is anticipated to be completed by the end of January 2019. A recent article further discussing LXRP reads, “Having the work done in-house will help expand the work schedule and reduce costs and development timelines. The company is currently recruiting new staff as it prepares for an increase in…

MondayDec 17, 2018 9:45 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Hires Key Personnel, Plans to Expand Lab Staff for R&D in 2019 and Issues Stock Options

LXRP is putting its growth plan into effect, adding a new corporate controller, a head of its legal division and more office staff; in 2019, it will also be increasing its lab personnel As a result of the latest positions created, the company is issuing 240,000 new stock options with an exercise price of $1.06 that will vest as to 80,000 per year until April 15, 2021 LXRP has a growing IP portfolio of 10 patents granted in the U.S. and Australia; it has filed for more than 50 patents worldwide across 10 patent families Lexaria Bioscience Corp. (CSE: LXX)…

MondayDec 10, 2018 9:35 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Expanding Personnel, Issues Stock Options

Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) on Friday announced that it is expanding to hire new personnel and will be issuing stock options. Per the update, Lexaria is in the process of appointing a new corporate controller, head of its legal division and other office staff, and, in 2019, it expects to hire additional laboratory personnel with expansion of its research and development operations. As a result of the newly-created positions, Lexaria is issuing stock options totaling 240,000 with an exercise price of $1.06. In addition, the company has received $110,000 from…

FridayDec 07, 2018 11:58 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Leveraging Technology to Formulate ChrgD+ Premium Brand with Cultivating Wellness Inc.

Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) recently leveraged the trademarked ability of its DehydraTECH technology to deliver cannabinoids by entering a new partnership with Cultivating Wellness Inc. (“CW”) to formulate the ChrgD+ premium brand. A recent article discussing the company reads, “LXRP’s partnership with Cultivating Wellness Inc. (“CW”), which formulated the product, is seen as an important combined effort (http://ibn.fm/HALyy). … LXRP has not only partnered with CW as the manufacturer of ChrgD+; it also serves as the distributor of the product to its national network of customers, such as convenience stores, specialty…

TuesdayDec 04, 2018 11:26 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Submits Application for Research License to Health Canada

Lexaria has developed its DehydraTECH technology The company also has four new subsidiaries Lexaria recently submitted its application to Health Canada for a research license Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a research-driven company that has developed and out-licenses its DehydraTECH technology – a drug delivery platform. It is the only company globally with a patent issued for oral delivery of all cannabinoids. The company’s technology facilitates the delivery of bioactive substances via oral ingestion without the need for inhalational dosing or co-administration with sugars or sweeteners. Lexaria Bioscience is headquartered in Kelowna, British Columbia. Lexaria has four…

MondayDec 03, 2018 11:00 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Submits Application for Research License and Appoints New Member to Executive Team

Submitted application to Health Canada for license that will allow in-house research in new facility Appointed Dr. Ed Ergenzinger to executive team as chief legal officer and senior VP of innovation Recruiting new staff, expanding work schedules and reducing costs and development timelines Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a biotech company and drug delivery platform innovator, announced in a recent press release (http://ibn.fm/40WPx) that it has submitted a Health Canada research application and has appointed a new member to its executive team. The research application has been submitted for the operation of a Kelowna-based research and development laboratory to…

WednesdayNov 28, 2018 12:04 pm

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Mobile Hemp Oil Supplement Powder Packet, ChrgD+, Utilizes DehydraTECH Technology

LXRP partners with Cultivating Wellness Inc. (“CW”) to formulate the ChrgD+ premium brand and will now focus on selling it to CW’s national distribution network of retailers The two-gram powder packets are water soluble and can be added to any hot/cold beverage; they are a ready-mix hemp oil supplement that can be added to drinks, such as coffee DehydraTECH has already received multiple patents, and LXRP is a drug delivery platform innovator; the introduction is seen as a first step in the relationship between the companies Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) introduction of ChrgD+ powder packets, which can…

Site Search

Company Search

Tag: Lexaria Bioscience Corp. LXRP